Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Other Non-Current Assets (2016 - 2025)

Conmed's Other Non-Current Assets history spans 16 years, with the latest figure at $137.2 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 17.9% year-over-year to $137.2 million; the TTM value through Dec 2025 reached $137.2 million, up 17.9%, while the annual FY2025 figure was $137.2 million, 17.9% up from the prior year.
  • Other Non-Current Assets reached $137.2 million in Q4 2025 per CNMD's latest filing, down from $148.3 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $148.3 million in Q3 2025 to a low of $93.9 million in Q4 2022.
  • Average Other Non-Current Assets over 5 years is $112.5 million, with a median of $107.3 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: decreased 4.98% in 2022, then surged 37.84% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $98.8 million in 2021, then decreased by 4.98% to $93.9 million in 2022, then grew by 2.38% to $96.1 million in 2023, then rose by 21.07% to $116.4 million in 2024, then increased by 17.9% to $137.2 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Other Non-Current Assets are $137.2 million (Q4 2025), $148.3 million (Q3 2025), and $145.1 million (Q2 2025).